In this study, we for the first time, proposed a new independent biomarker C5a, which was significantly associated with overall survival of ccRCC patients, especially in TNM advanced stage and SSIGN intermediate/high risk patients. This evidence concerns the gene C5AR1 and nonpapillary renal cell carcinoma.